Korea proposes elimination of in-country device testing requirements.
This article was originally published in The Gray Sheet
Executive Summary
KOREAN DEVICE REGULATION PROPOSED REVISIONS ELIMINATE IN-COUNTRY TESTING by Korean testing houses as a prerequisite to marketing clearance. An outline of proposed revisions to the program recently provided to the Health Industry Manufacturers Association indicates that in the future, the Republic of Korea Ministry of Health and Welfare (MOHW) plans to accept a "certificate of testing results" in lieu of in-country testing. The certificates could be issued only by "testing agencies designated by" MOHW, the outline says, but "certificates of testing results issued by foreign certified testing agencies which meet certain standards" would be "recognized."
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.